Company name Medivation, Inc.
Stock ticker MDVN
Live stock price [stckqut]MDVN[/stckqut]
Confident Investor Rating Poor

The following company description is from Google Finance: http://www.google.com/finance?q=mdvn

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases, for which there are limited treatment options. Its product candidates in clinical development are MDV3100, which is in Phase 3 development for the treatment of advanced prostate cancer, and dimebon (latrepirdine), which is in Phase 3 development for the treatment of Alzheimer�s disease and Huntington disease. Its MDV3100 program is partnered with Astellas Pharma Inc. (Astellas, and its dimebon program is partnered with Pfizer Inc. (Pfizer).

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock. It is not possible to confidently invest in a company that is not currently profitable.

Company name Landstar System, Inc.
Stock ticker LSTR
Live stock price [stckqut]LSTR[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Poor
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $68.25
Target stock price (averages with growth) $94.31
Target stock price (averages with no growth) $72.47
Target stock price (manual assumptions) $74.49

The following company description is from Google Finance: http://www.google.com/finance?q=lstr

Landstar System, Inc. (Landstar) is a non-asset based provider of freight transportation services and supply chain solutions. The Company offers services to its customers across multiple transportation modes. Landstar provides services throughout the United States and Canada and between the United States and Canada, Mexico and other countries globally. The Company�s services are delivered through a network of independent commission sales agents and third party capacity providers linked together by a series of information technology systems, which are provided and coordinated by the Company. Landstar utilizes third party capacity providers to transport and store customers’ freight. The Company operates in two segments: the transportation logistics segment and the insurance segment.

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

Company name Illumina, Inc.
Stock ticker ILMN
Live stock price [stckqut]ILMN[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Poor
Sales growth Poor
EPS growth Poor
P/E growth Poor
EBIT growth Poor
ANALYSIS
Confident Investor Rating Poor
Target stock price (TWCA growth scenario) $4.37
Target stock price (averages with growth) $10.97
Target stock price (averages with no growth) $18.41
Target stock price (manual assumptions) $5.92

The following company description is from Google Finance: http://www.google.com/finance?q=ilmn

Illumina, Inc. (Illumina) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. The Company provides a line of genetic analysis solutions, with products and services that serve a range of interconnected markets, including sequencing, genotyping, gene expression, and molecular diagnostics. The Company is organized in two business segments: Life Sciences and Diagnostics. Its Life Sciences business unit includes all products and services related to the research market, namely the product lines based on its sequencing, BeadArray, VeraCode, and real-time PCR technologies. Its Diagnostics business unit focuses on molecular diagnostics. Its customers include genomic research centers, academic institutions, government laboratories, and clinical research organizations. In January 2011, the Company acquired Epicentre Technologies Corporation. In April 2010, the Company purchased Helixis, Inc.

Confident Investor comments: Unfortunately, it is difficult for a company to be profitable and still have this much red. At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock.

Company name Harris Corporation
Stock ticker HRS
Live stock price [stckqut]HRS[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Fair
Sales growth Fair
EPS growth Fair
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $45.06
Target stock price (averages with growth) $55.13
Target stock price (averages with no growth) $50.94
Target stock price (manual assumptions) $41.27

The following company description is from Google Finance: http://www.google.com/finance?q=hrs

Harris Corporation (Harris), together with its subsidiaries, is an international communications and information technology company serving government and commercial markets in more than 150 countries. The Company operates in three segments: RF Communications segment, Government Communications Systems segment and Broadcast Communications segment. Its RF Communications segment consists of its tactical radio communications and public safety and professional communications businesses. Its Government Communications Systems segment consists of its defense programs, national intelligence programs, civil programs and information technology (it) services businesses. Its Broadcast Communications segment consists of its workflow, infrastructure and networking solutions, media and transmission systems businesses. On May 28, 2010, the Company acquired privately held SignaCert, Inc. In April 2011, the Company completed the acquisition of Global Connectivity Services business.

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.